RNTX Q1 2026 Earnings EPS Beats Estimates as Preclinical Stage Biotech Tightens Spending WATT Q1 2026 Earnings EPS Surprise of 3464 Despite No Revenue Stock Declines AVTX Q1 2026 Earnings Narrowing Loss Per Share Offers Some Relief but Stock Fragility Persists QCLS Q4 2017 Earnings Massive EPS Miss Fails to Deter Investors UNB Q2 2025 Earnings Solid EPS Performance Amidst Quiet Quarter ALZN Q1 2026 Earnings Narrowing Losses Beat Estimates by 70